Background: To systematically evaluate the effectiveness and mechanism of Zhengan Xifeng Decoction in the treatment of ischemic stroke based on network pharmacology research methods. Methods: The active ingredients of Zhengan Xifeng Decoction were collected by TCMSP. Uniprot database was used to obtain the list of potential targets of active ingredients of Zhengan Xifeng Decoction. GeneCards and OMIM databases were used to obtain ischemic stroke disease-related targets. String website was used to construct protein interaction network (PPI). Metascape was used for GO enrichment and KEGG pathway enrichment analysis. Results: 183 effective active components, 415 targets and 1022 disease-related targets of Zhengan Xifeng Decoction were screened by network pharmacology, and 136 intersection gene targets were obtained. PPI analysis revealed that the key targets involved TNF, AKT1, IL6, IL1B, VEGFA, etc. Enrichment analysis obtained 2076 GO items (P < 0.01) and 193 KEGG items (P < 0.01).

Hui Ren, Ju Tang, Feng Miao. The efficacy and mechanism of Zhengan Xifeng Decoction in the treatment of ischemic stroke: a network pharmacology study. Frontiers in Medical Science Research (2023) Vol. 5, Issue 5: 85-93. https://doi.org/10.25236/FMSR.2023.050513.

[1] Mendelson SJ, Prabhakaran S. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review[J]. JAMA, 2021, 325(11):1088-1098.

[2] Leslie-Mazwi T, Chandra RV, Fraser JF, et al. AHA/ASA 2018 AIS guidelines: impact and opportunity for endovascular stroke care [J]. Neurointerv Surg, 2018, 10(9):813-817.

[3] Cao Simin, Li Guang. Progress in the research of the decoction in the treatment of vascular diseases [J]. Bachu Medicine, 2021, 4 (01): 103-104 + 125.

[4] Chen Longfei, Li Jianai, Zhang Chunyan. Efficacy of acute ischemic stroke and its effect on vascular endothelial function [J]. Prescription drugs in China, 2019, 17 (09): 143-144.

[5] Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines [J].J Cheminform, 2014, 6:13.

[6] UniProt Consortium. UniProt: the universal protein knowledgebase in 2021[J].Nucleic Acids Res, 2021, 49(D1):D480-D489.

[7] Rappaport N, Twik M, Plaschkes I, et al. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search [J]. Nucleic Acids Res, 2017, 45(D1): D877-D887.

[8] Barshir R, Fishilevich S, Iny-Stein T, et al. GeneCaRNA: A Comprehensive Gene-centric Database of Human Non-coding RNAs in the GeneCards Suite[J]. J Mol Biol, 2021, 433(11):166913.

[9] Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets[J].Nucleic Acids Res, 2019, 47(D1):D607-D613.

[10] Zhou Y, Pache L, Chang M, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J].Nat Commun, 2019, 10(1):1523.

[11] Mendelson SJ, Prabhakaran S. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review [J]. JAMA, 2021, 325(11):1088-1098.

[12] Yang Ran, Shen Yanjia, Li Li, et al. Protective effect of quercetin on the blood-brain barrier in rats with ischemic stroke [J]. Chinese Journal of Pharmacology and Toxicology, 2019, 33 (09): 726.

[13] Jiang YH, Li X, Niu W, et al .β-Sitosterol regulated microRNAs in endothelial cells against an oxidized low-density lipoprotein[J].Food Funct, 2020, 11(2):1881-1890.

[14] Koo HJ, Park HJ, Byeon HE, et al. Chinese yam extracts containing β-sitosterol and ethyl linoleate protect against atherosclerosis in apolipoprotein E-deficient mice and inhibit muscular expression of VCAM-1 in vitro[J]. J Food Sci, 2014, 79(4):H719-29.

[15] Wu B, Luo H, Zhou X, et al. Succinate-induced neuronal mitochondrial fission and hexokinase II malfunction in ischemic stroke: Therapeutical effects of kaempferol [J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(9):2307-2318.

[16] Wang Tingting, Li Yan, Zhang Mingming, et al. Investigation of the mechanism that isrhamsin increases atherosclerotic plaque stability by inhibiting foam cell formation [J]. Journal of Cardiology, Cardiology, 2022, 30 (02): 69-74.

[17] Tuttolomondo A, Pecoraro R, Pinto A. Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date [J]. Drug Des Devel Ther, 2014, 8:2221-38.

[18] Wang Q, Tang X N, Yenari M A. The inflammatory response in stroke [J]. J Neuroimmunol, 2007, 184(1-2): 53-68.

[19] Yu Di, Mo Xuming. Protective effects of PI3K / Akt and MAPK signaling in ischemic brain injury [J]. Medical Review, 2015, 21 (02): 210-213.

[20] Moon S, Chang MS, Koh SH, et al. Repair Mechanisms of the Neurovascular Unit after Ischemic Stroke with a Focus on VEGF [J]. Int J Mol Sci, 2021, 22(16):8543.

[21] Geiseler SJ, Morland C. The Janus Face of VEGF in Stroke [J]. Int J Mol Sci, 2018, 19(5):1362.

[22] Prasad K. Pathophysiology and Medical Treatment of Carotid Artery Stenosis [J]. Int J Angiol, 2015, 24 (3): 158-72.

[23] Tobinick E, Kim NM, Reyzin G, et al. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept [J]. CNS Drugs, 2012, 26(12):1051-70.